Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The NIPA Study: A Randomized Double-blind Control Clinical Trial Naloxegol Administration to Prevent Opioids Induced Gastrointestinal Motility Disturbance in Brain Injured PAtients

NCT05008926 is registered in ClinicalTrials.gov with University Hospital, Brest as lead sponsor.

NCT NCT05008926
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05008926 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The NIPA Study: A Randomized Double-blind Control Clinical Trial Naloxegol Administration to Prevent Opioids Induced Gastrointestinal Motility Disturbance in Brain Injured PAtients
Lead sponsor
University Hospital, Brest
Phase
Phase 3
Overall status
Suspended
Start date
March 15, 2022
Completion date
April 26, 2028
Enrollment
370 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

brain injuries